As of March 1, 2024, an article processing charge (APC) of USD 400 + 20% VAT will be requested for newly submitted research, review, meta-analysis articles to the Anatolian Journal of Cardiology if they are accepted for publication.
Should systemic thrombolytic therapy be considered a first-line treatment in acute pulmonary embolism?
Orhan Gökalp1, Yüksel Beşir2, Börtecin Eygi2, Gamze Gökalp31Department of Cardiovascular Surgery, Faculty of Medicine, İzmir Katip Çelebi University; İzmir-Turkey 2Department of Cardiovascular Surgery, İzmir Katip Celebi University, Atatürk Education and Research Hospital; İzmir-Turkey 3Department of Pediatric Emergency, Tepecik Education and Research Hospital; İzmir-Turkey
Akut pulmoner emboli tedavisinde sistemik trombolitik tedavi kullanımı ilk tercih mi dir?
Orhan Gökalp1, Yüksel Beşir2, Börtecin Eygi2, Gamze Gökalp31Department of Cardiovascular Surgery, Faculty of Medicine, İzmir Katip Çelebi University; İzmir-Turkey 2Department of Cardiovascular Surgery, İzmir Katip Celebi University, Atatürk Education and Research Hospital; İzmir-Turkey 3Department of Pediatric Emergency, Tepecik Education and Research Hospital; İzmir-Turkey
Orhan Gökalp, Yüksel Beşir, Börtecin Eygi, Gamze Gökalp. Should systemic thrombolytic therapy be considered a first-line treatment in acute pulmonary embolism?. Anatol J Cardiol. 2015; 15(1): 82-83 Manuscript Language: English